We continuously exposed the EZH2-mutant lymphoma cell line DB to increasing concentrations of EPZ-6438 for 6 weeks to develop an EPZ-6438-resistant line (DB-r) (Supplementary Fig. 9e). The gene discussed is EZH2; the disease is lymphoma.